# EDGAR Filing Document

**Accession Number:** 0001430306
**File Stem:** 0001999371-25-012500
**Filing Date:** 2025-9
**Character Count:** 2290
**Document Hash:** d7fb14fad51ad746833372728cc9f726
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-012500.hdr.sgml**: 20251121

**ACCESSION NUMBER**: 0001999371-25-012500

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250903

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tonix Pharmaceuticals Holding Corp.
- **CENTRAL INDEX KEY:** 0001430306
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 261434750
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 26 MAIN STREET, SUITE 101
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928
- **BUSINESS PHONE:** 212-980-9155

**MAIL ADDRESS:**
- **STREET 1:** 26 MAIN STREET, SUITE 101
- **CITY:** CHATHAM
- **STATE:** NJ
- **ZIP:** 07928

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TAMANDARE EXPLORATIONS INC.
- **DATE OF NAME CHANGE:** 20080320

**Tonix Pharmaceuticals Holding Corp.**

**26 Main Street, Suite 101**

**Chatham, New Jersey 07928**

September 3, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Tonix Pharmaceuticals Holding Corp.** |
|  | **Registration Statement on Form S-3 (File No. 333-287965)** |
|  | **Filed on June 12, 2025** |

---

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on August 29, 2025, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for September 3, 2025, at 4:00 p.m., Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 with any questions.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| TONIX PHARMACEUTICALS HOLDINGS CORP. | TONIX PHARMACEUTICALS HOLDINGS CORP. |
| By: | /s/ Bradley Saenger |
| Name: | Bradley Saenger |
| Title: | Chief Financial Officer |

---